TRIM34 acts with TRIM5 to restrict HIV and SIV capsids
Molly OhAinle(Fred Hutch Cancer Center), Michael Emerman(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 1
Related Papers
Convergence and Divergence in the Evolution of the APOBEC3G-Vif Interaction Reveal Ancient Origins of Simian Immunodeficiency Viruses
|PLoS Pathogens|2013|118
A Virus-Packageable CRISPR System Identifies Host Dependency Factors Co-Opted by Multiple HIV-1 Strains
|mBio|2023|12
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor
|Retrovirology|2023|7
A Virus-Packageable CRISPR Screen Identifies Host Factors Mediating Interferon Inhibition of HIV
|bioRxiv (Cold Spring Harbor Laboratory)|2018|4
Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms
|bioRxiv (Cold Spring Harbor Laboratory)|2021|3